Differential regulation by leukotrienes and calcium of FcÎ³ receptorâ  induced phagocytosis and Syk activation in dendritic cells versus macrophages by Canetti, Claudio et al.
Differential regulation by leukotrienes and calcium of Fc
receptor-induced phagocytosis and Syk activation in
dendritic cells versus macrophages
Claudio Canetti,*,† David M. Aronoff,*,‡ Mun Choe,* Nicolas Flamand,* Scott Wettlaufer,*
Galen B. Toews,* Gwo-Hsiao Chen,* and Marc Peters-Golden*,1
Divisions of *Pulmonary and Critical Care Medicine and ‡Infectious Diseases, University of Michigan Health
System, Ann Arbor; and †Departamento de Farmacologia, Universidade do Estado do Rio de Janeiro, Brazil
Abstract: Macrophage (MØ) phagocytosis via
the Fc receptor for immunoglobulin G (FcR)
requires the spleen tyrosine kinase (Syk) and
serves an important antimicrobial function. We
have reported previously that FcR-mediated in-
gestion and Syk activation in MØ are amplified by
and depend on the proinflammatory lipid media-
tor leukotriene B4 (LTB4). Although FcR-me-
diated ingestion is also important for antigen
uptake, there is no information about LTB4 reg-
ulation of these processes in dendritic cells
(DCs). In this study, we compared murine bone
marrow (BM)-derived DCs to MØ from BM, peri-
toneum, and the pulmonary alveolar space. Nei-
ther phagocytosis nor Syk activation in DCs was
influenced by exogenous LTB4. Unlike the vari-
ous MØ populations, Syk activation in DCs was
likewise unaffected by pharmacologic or genetic
strategies to inhibit endogenous LTB4 synthesis
or to block the high-affinity LTB4 receptor
BLT1. DCs were refractory to regulation by
LTB4 despite the fact that they expressed BLT1
and mobilized intracellular calcium in response
to its ligation. This resistance to LTB4 in DCs
instead reflected the fact that in contrast to MØ,
Syk activation in DCs was itself entirely indepen-
dent of calcium. These results identify a funda-
mental difference in FcR signaling between DCs
and MØ, which may relate to the divergent, func-
tional consequences of target ingestion in the two
cell types. J. Leukoc. Biol. 79: 1234–1241;
2006.
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INTRODUCTION
Phagocytosis is a key process for immune responses initiated
by dendritic cells (DCs) and macrophages (MØ). Among sev-
eral mechanisms of internalization, the ingestion of immuno-
globulin G (IgG)-opsonized targets via the Fc receptor for IgG
(FcR) is essential for DCs to process and subsequently
present antigens to T lymphocytes in acquired immunity and
for MØ to clear microbes in innate immunity.
The protein spleen tyrosine kinase (Syk) plays an essential
role in various signaling cascades necessary for immune cell
responses, including the ingestion of IgG-coated targets by MØ
[1] and DCs [2]. Following FcR engagement, the two N-
terminal Src homology 2 domains of Syk bind to the immuno-
receptor tyrosine-based activation motifs of the -chain of
FcRI and FcRIII and with the cytoplasmic domain of
FcRIIA. Following this interaction, Syk becomes phosphory-
lated on tyrosine and is itself activated, initiating a cascade of
signaling events leading to actin polymerization and phagocy-
tosis [3, 4].
Leukotrienes (LTs) are lipid mediators of inflammation de-
rived from the 5-lipoxygenase (5-LO) pathway of arachidonic
acid (AA) metabolism. The enzyme 5-LO, in conjunction with
its helper protein 5-LO-activating protein (FLAP), oxygenates
AA to form LTA4. This intermediate can be hydrolyzed to form
the potent leukocyte activator and chemoattractant LTB4 or
conjugated with glutathione to form cysteinyl-LTs (cysLT;
LTC4, LTD4, and LTE4), which elicit smooth muscle contrac-
tion and microvascular permeability [5]. Important in vivo roles
for LTs have been established in acquired [6, 7] and innate [8]
immune responses.
We have demonstrated previously that endogenous and ex-
ogenous LTB4 enhances FcR-induced phagocytosis in MØ [9]
and neutrophils [10]. One mechanism by which LTB4 does so
in MØ is by amplifying FcR-induced Syk activation, a pro-
cess that was itself dependent on Ca2 influx [11]. In the
present study, we sought to extend this work to DCs by eval-
uating the role of LTB4 in modulating FcR-induced phago-
cytosis and Syk activation in these professional antigen-pre-
senting cells (APC). In contrast to our findings with MØ, we
now demonstrate that FcR-induced phagocytosis in DCs is
independent of LTB4 and that Syk activation in DCs is itself
independent of LTB4 and Ca
2.
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MATERIALS AND METHODS
Animals
Seventeen 5-LO knockout (KO; 129-Alox5tm1Fun) mice on a 129 background
were bred in the University of Michigan Unit for Laboratory Animal Medicine
(Ann Arbor) from breeders obtained from The Jackson Laboratories (Bar
Harbor, ME). Strain-matched wild-type (WT) mice as well as CBA mice and
Wistar rats were obtained from Charles River Laboratories (Portage, MI). The
University Committee on Use and Care of Animals approved animal protocols.
Generation of bone marrow (BM)-derived DCs
(BM-DCs) and BM-derived MØ (BM-MØ)
BM cells were harvested from flushed marrow cavities of femurs and tibiae of
mice under aseptic conditions. BM-DCs were generated from mouse BM cells
(1106 cells/ml) cultured for 4 days in culture medium [RPMI with 10% fetal
calf serum (FCS)], supplemented with 20 ng/ml granulocyte MØ-colony stim-
ulating factor (GM-CSF; PeproTech, Rocky Hill, NJ) and 20 ng/ml interleukin
(IL)-4 (PeproTech), as described by Asavaroengchai et al. [12]. The BM-DC
population was enriched by collecting the low-density interface following
14.5% (by weight) metrizamide density gradient centrifugation (15 min, 4°C,
2000 revolutions per minute) and washing twice in Hanks’ balanced saline
solution (HBSS). Purified BM-DCs (90% purity) were further cultured in 60
mm dishes at 1  106 cells/ml for 24 h before use.
Flow cytometry analysis of cell surface antigens
To prevent nonspecific FcR-mediated staining, the cell suspension (except
the one for FcR staining) was preincubated with anti-CD16/CD32 (FcRIII/
II) monoclonal antibody (mAb), according to the manufacturer’s instructions
(PharMingen, San Diego, CA). The following mAb were used for staining of
surface antigens: anti-F4/80 (murine MØ marker), anti-CD16/CD32 (FcRIII/
II), anti-CD11c (integrin x chain), anti-CD80 (B7-1), anti-CD86 (B7-2),
anti-I-Ak [major histocompatibility complex (MHC) class II], and the appro-
priate isotype controls (all from PharMingen). For flow cytometry, the cells
were adjusted to a concentration of 5  106 cells/ml in staining buffer
[fluorescent assay (FA) buffer (Difco, Detroit, MI) with 0.1% sodium azide and
1% FCS]. Cells (5105) were stained with saturating antibody concentrations
for 30 min at 4°C. The samples were washed in FA buffer and fixed with 1%
paraformaldehyde (Sigma Chemical Co., St. Louis, MO) in buffered saline.
Stained samples were stored in the dark at 4°C until analyzed on a flow
cytometer (Coulter Elite ESP, Palo Alto, CA). Flow cytometry data were
analyzed by using the FlowJo 5.4.5 software (Tree Star, San Carlos, CA).
Adherent BM-DCs used in this study were considered to be immature
BM-DCs, a fact confirmed by flow cytometry, demonstrating a higher expres-
sion of CD11c [mean fluorescence intensity (MFI) of 110.1 vs. 87.6] and FcR
(MFI 73.1 vs. 47.1) and a lower expression of MHC class II (MFI 75.6 vs.
159.5), CD80 (MFI 88.1 vs. 200.4), and CD86 (MFI 77.7 vs. 138.7), as
compared with more mature, nonadherent BM-DCs. BM-MØ (95% pure)
were obtained from mouse BM cells prepared as described above and cultured
at 1  106 cells/ml for 6 days in medium (RPMI with 10% FCS) supplemented
with 20 ng/ml GM-CSF following a modified protocol published previously
[13].
Isolation and culture of alveolar and
peritoneal MØ
Resident alveolar MØ were obtained by lung lavage from rats as described
previously [14]. Resident peritoneal MØ were harvested by peritoneal lavage of
mice with 5 ml Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Grand
Island, NY). The cell suspensions were enumerated using a hemocytometer,
adhered in flat-bottom, six-well plates (Becton Dickinson, Franklin Lakes, NJ)
for 1 h at 37°C in a 5% CO2 atmosphere, and nonadherent cells were removed
by washing. After adherence, the cultures were composed of more than 98%
MØ, as assessed by a modified Wright-Giemsa stain (Diff-Quik, American
Scientific Products, McGaw Park, IL). MØ monolayers were cultured overnight
in DMEM with 10% fetal bovine serum (HyClone Laboratories, Logan, UT).
The cells were washed, and the medium changed to DMEM without serum 20
min before the challenge with phagocytic targets.
Microcolorimetric erythrocyte phagocytosis
assay
The phagocytosis of sheep red blood cells (sRBCs) was assessed as described
previously [15]. Briefly, BM-DCs, BM-MØ, and rat alveolar MØ were plated for
24 h in 96-well, culture-treated dishes (BD Biosciences, San Jose, CA) at a
density of 2  105 cells/well. Cells were then washed twice with warm DMEM
and preincubated with the phagocytosis inhibitor cytochalasin D (Cyto D; 5
g/ml, 45 min), LTC4 (10 nM, 2 min, Cayman Chemical, Ann Arbor, MI), or
LTB4 (10 nM, 2 min, Cayman Chemical). RBCs (ICN Pharmaceuticals, Costa
Mesa, CA) were opsonized with a subagglutinating concentration of polyclonal
rabbit anti-sRBC IgG (Cappel Organon Teknika, Durham, NC) as described
previously [16]. Following preincubation, opsonized RBCs were added at a
target:cell ratio of 50:1, and cultures were incubated for an additional 90 min
at 37°C. Wells were then washed three times with phosphate-buffered saline
(PBS) to remove noningested erythrocytes, and 100 l 0.3% sodium dodecyl
sulfate (SDS) in PBS was added to each well for 10 min. Serial dilutions of
known amounts of RBCs were added to separate wells before the addition of the
SDS solution to derive a standard curve. Lastly, 100 l o-phenylenediamine
dihydrochloride solution was added to each well as a chromogen. Following a
30-min incubation (at 22°C) in the dark, the absorbance at 450 nm was
evaluated with an automated reader (VERSAmax, Molecular Devices, Sunny-
vale, CA). The number of RBCs per well was derived from absorbance data at
450 nm using the standard curve made with known amounts of RBCs. Inde-
pendent experiments were performed in septuplet.
Quantification of fluorescein isothiocyanate
(FITC)-dextran endocytosis by flow
cytometry analysis
To analyze endocytosis, cells (2106) were incubated in RPMI-1640 medium
containing 3% FCS and incubated with FITC-dextran (Sigma Chemical Co.) at
a final concentration of 1 mg/ml at 37°C for 60 min, as described previously
[17]. After incubation, cells were washed with ice-cold FA buffer, then fixed in
4% paraformaldehyde, and were analyzed by flow cytometry. The FITC-dextran
uptake was determined as the mean fluorescence relative to the background
staining of the respective sample incubated with FITC-dextran at 4°C.
Mixed leukocyte reaction (MLR)
To assess lymphocyte proliferation in response to APC, RBC-depleted, allo-
geneic spleen cells were cultured in triplicate at 5  105 cells/well in 96-well
plates together with 104 BM-DCs or BM-MØ cells as stimulators in a total
volume of 200 l RPMI-1640 medium containing 10% heat-inactivated FCS.
Prior to culture, stimulator cells were irradiated (3000 rads; 137Cs source).
DNA synthesis was assessed over the last 16 h of a 72-h culture by addition
of 1 mCi/well 3H-thymidine (Amersham, Arlington Heights, IL). Cells were
harvested onto glass fiber filters and placed in scintillation fluid (Scintiverse,
Fisher Chemicals, Fair Lawn, NJ) for measurement of label incorporation in a
liquid scintillation counter (Beckman Coulter, Fullerton, CA). Responses were
reported as mean counts per minute (cpm)  SEM of triplicate samples.
Controls included responders or stimulators alone. Background 3H-thymidine
incorporation as a result of stimulators alone was 	500 cpm.
Immunoprecipitation
Cell monolayers were lysed in buffer containing 1% Triton X-100 and 50 mM
tris(hydroxymethyl)aminomethane (Tris; pH 8.0), 100 mM NaCl, 1 mM
Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 50 mM NaF, and 1 g/mL
leupeptin. Lysates were precleared with protein A-Sepharose for 30 min and
incubated overnight at 4°C with anti-Syk (1:80, Santa Cruz Biotechnology,
CA). Protein A-Sepharose was added to each sample and incubated for 3 h with
rotation at 4°C. The beads were washed briefly three times with lysis buffer
without Triton X-100 and separated on 8% SDS-polyacrylamide gel electro-
phoresis. The entire volume recovered after boiling the beads was loaded onto
the gel; lysates are derived from equal numbers of cells, but total Syk per lane
was subject to variation. The proteins were transferred to nitrocellulose mem-
branes (Schleicher and Schuell, Keene, NH) overnight at 100 amps and for 3 h
at 200 mA.
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Immunoblotting
The membrane was blocked with 5% fat-free milk in Tris-buffered saline
containing 0.1% Tween 20 for 1 h, washed three times, and then probed with
antiphosphotyrosine (anti-PY; 1:900, PY20, Transduction Laboratories, Lex-
ington, KY) for 1.5 h. After that, the membrane was washed and incubated with
a horseradish-peroxidase (HRP)-conjugated sheep anti-mouse secondary an-
tibody (1:15,000, Amersham Pharmacia Biotech, Piscataway, NJ). Phosphor-
ylated bands were visualized using the enhanced chemiluminescence (ECL)
system (Amersham). The membranes were then stripped, blocked, and re-
probed with anti-Syk (1:800) for 1 h, followed by an incubation with HRP-
conjugated donkey anti-rabbit secondary antibody (1:20,000, Amersham Phar-
macia Biotech). The bands were visualized using the ECL system. Relative
band densities were determined by densitometric analysis using National
Institutes of Health Image software, and the ratios were calculated. The results
were expressed as normalized Syk-PY/Syk, which represents the value of
density obtained with the anti-PY blot divided by the value obtained with the
anti-Syk blot. In all instances, density values of bands were corrected by
subtraction of the background values.
Analysis of calcium mobilization
Adherent cells were harvested using the protease cocktail AccutaseTM (eBio-
science, San Diego, CA) according to the manufacturer’s instructions, centri-
fuged for 5 min at 750 g, and then resuspended in HBSS containing 1.6 mM
CaCl2. The warmed cell suspension (37°C, 10
7 cells/ml) was treated with 10
M Fura-2-acetoxymethyl ester (AM) for 30 min, then washed twice with
HBSS containing 1.6 mM CaCl2, and finally resuspended at a density of 10
7
cells/ml and transferred into the magnetically stirred cuvette of the lumines-
cence spectrometer (Perkin Elmer LS50B, Perkin Elmer, Wellesley, MA).
Calcium mobilization was monitored using excitation wavelengths of 340 and
380 nm and an emission wavelength of 510 nm. Data are presented as the ratio
of fluorescence obtained from 340 and 380 (340/380) nm.
RNA extraction and reverse transcriptase-
polymerase chain reaction (RT-PCR)
Total RNA was extracted using Trizol reagent, following the manufacturer’s
instructions (Invitrogen, Carlsbad, CA), and quantified by spectrophotometry.
The PCR master mix was made from a Promega (Madison, WI) access RT-PCR
system kit. It is a two-enzyme system, which allows an avian myloblastosis
virus RT to process the RNA into cDNA in the first step and a Tfl DNA
polymerase to facilitate the amplification over the number of desired cycles.
The primers were designed to anneal at 55°C. The primers used for the
amplification of mouse high-affinity LTB4 receptor BLT1 cDNA were (sense)
5
-GCAGTGGCCCGCCCCTTTATGTC-3
 and (antisense) 5
-CACCGGGT-
TCACGCTGCTGCTC-3
 and for BLT2, were (sense) 5
-GTAGTATGGAGCT-
TAGCGGGC-3
 and (antisense) 5
-GGGTCTCCAGGCTCAGATG-3
. Follow-
ing the amplification, the DNA product was loaded on a 1.5% agarose gel. The
DNA was then transferred to a nitrocellulose membrane in NaOH (to separate
the DNA strands) and probed with a 32P-labeled probe made specifically for
the primer product. After hybridization, the membrane was exposed to photo-
graphic film.
Statistical analysis
The data are reported as a representative blot from two or three different
experiments. Graphs represent the mean  SEM from two or three different
experiments. The means from different treatments were compared by ANOVA.
When significant differences were identified, individual comparisons were
subsequently made with the Bonferroni test for unpaired values. Statistical
significance was set at a P value less than 0.05.
RESULTS
Surface marker profiles of BM-MØ and BM-DCs
To determine whether BM-MØ and BM-DCs are phenotypically
distinct subpopulations, we used flow cytometry to analyze the
surface markers expressed on both cell types (Fig. 1A).
BM-MØ showed a moderate expression of the MØ marker
F4/80, whereas BM-DCs expressed this weakly. Both popula-
tions exhibited FcR expression, although BM-DCs expressed
slightly higher levels than BM-MØ. BM-DCs expressed high
levels of CD11c and CD80 and also exhibited slightly higher
levels of costimulatory molecules CD86 and MHC class II
antigen compared with BM-MØ. In summary, the results con-
firm that BM-MØ and BM-DCs are phenotypically distinct
populations based on their surface antigen expression patterns.
FITC-dextran endocytosis of BM-MØ
and BM-DCs
To verify the functional phenotype of the isolated cells, we
evaluated the capacity of BM-MØ and BM-DCs to perform
mannose receptor-mediated phagocytosis of FITC-dextran.
Flow cytometric analysis showed that BM-DCs exhibited
slightly better capacity to internalize FITC-dextran than did
BM-MØ. Approximately 87% of BM-DCs became FITC-dex-
tran-positive, and MFI of the cells incorporated FITC-dextran
of 51.2 after 1 h of incubation; by comparison, 79% of BM-MØ
were FITC-positive, and MFI of the cells was 37.7 (Fig. 1B).
Fig. 1. (A) Cell surface phenotypes of BM-MØ and BM-DCs. Light gray lines in the histogram show nonspecific fluorescence by subclass control mAb.
Fluorescence for the indicated antigens on BM-MØ and BM-DCs is shown by bold lines and shaded areas, respectively. This experiment was repeated three times
with similar results, and representative results are shown. (B) Endocytosis of FITC-dextran by BM-MØ and BM-DC cells, which were incubated with FITC-dextran
(1 mg/mL) for 1 h. Data are representative of three independent experiments.
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Antigen-presenting ability of BM-DCs
MLR was assessed to examine the differential antigen-present-
ing activity of BM-MØ and BM-DCs (Fig. 2). As expected,
BM-DCs significantly stimulated allogeneic splenocyte prolif-
eration, whereas BM-MØ provoked a slight proliferative re-
sponse, which did not reach statistical significance.
LTs do not modulate phagocytosis of IgG-sRBC
by BM-DCs
In previous reports, we demonstrated that phagocytosis of
IgG-coated particles by alveolar MØ was enhanced by the
5-LO products LTC4 and LTB4 [8, 9, 18]. By contrast, prein-
cubation of BM-DCs with LTC4 or LTB4 (each at 10 nM) did
not affect FcR-mediated phagocytosis (Fig. 3). Higher con-
centrations of the compounds (up to 100 nM) also failed to alter
phagocytosis (not shown). Confirming that the effects of exog-
enous LTs on alveolar MØ are true for other MØ cell types, we
found that LTC4 and LTB4 stimulated FcR-mediated inges-
tion by BM-MØ (Fig. 3). The concentrations of LTs used in
these studies were shown to enhance FcR-mediated phago-
cytosis by alveolar MØ in parallel experiments (data not
shown).
FcR-mediated Syk activation is not modulated
by LTB4 or by other 5-LO-derived products
Ligation of FcR by IgG is known to elicit activation (phos-
phorylation) of Syk in MØ [3] and DCs [19]. In MØ, this
process is amplified by LTB4 [11]. We used pharmacological
and genetic approaches to investigate whether Syk activation is
likewise modulated by LTB4 in BM-DCs. As can be seen in
Figure 4A, challenge of BM-DCs with IgG-opsonized sRBCs,
but not unopsonized sRBCs, elicited Syk phosphorylation.
However, treatment of BM-DCs with exogenous LTB4 (100 nM)
failed to amplify FcR-induced Syk activation. Moreover, Syk
activation was not influenced by endogenously produced LTB4,
as revealed by the use of a LTB4 receptor antagonist (LY
292476; Fig. 4B), agents that inhibit LT synthesis by inhibition
of 5-LO (zileuton) or of 5-LO-activating protein (MK 886; Fig.
4C), and cells from 5-LO/ mice (Fig. 5). As noted in Figure
5, there is no difference in Syk phosphorylation between BM-
DCs obtained from WT mice versus 5-LO/ mice upon stim-
ulation with several doses of IgG-coated RBCs.
BM-DCs express a functional LTB4 receptor
To evaluate whether the lack of effect of LTB4 on phagocytosis
and Syk activation in BM-DCs was a result of the absence of
the G protein-coupled BLT receptors, we first evaluated BLT1
and BLT2 messenger mRNA by RT-PCR. mRNA levels for
BLT1 and BLT2 were similar to those obtained using rat
alveolar MØ, and expression of the high-affinity BLT1 receptor
was also confirmed by Western blot analysis (data not shown).
Next, we examined calcium influx in BM-DCs in response to
LTB4 challenge, as it is well known that calcium mobilization
occurs immediately after LTB4 interaction with Gq-coupled
BLTs [20]. Stimulation of BM-DCs with LTB4 evoked a sub-
stantial increase in intracellular Ca2 concentration, as can be
observed in Figure 6, suggesting the presence of a functional
receptor in BM-DCs. Confirming the presence of BLT1 on
Fig. 2. Allogeneic MLR using BM-MØ and BM-DCs. Cells were irradiated
and cultured for 3 days with allogeneic spleen cells, and 3H-thymidine
incorporation was measured. *, P 	 0.05, compared with spleen cell alone; #,
P 	 0.05, compared with BM-MØ. Values are expressed as the mean  SEM
of triplicate samples. Results are representative of three independent experi-
ments.
Fig. 3. FcR-mediated phagocytosis is not affected by LTs
in BM-DCs. Mouse BM-DCs (A) or BM-MØ (B) were obtained
as described in Materials and Methods. Cells were pretreated
with the phagocytosis inhibitor Cyto D (5 g/ml) for 45 min
or LTC4 or LTB4 (each at 10 nM) for 2 min and then
challenged with IgG-opsonized RBCs. Phagocytosis (ingested
RBCs) was calculated based on a standard curve. *, P 	
0.05, compared with Cyto D-treated cells; #, P 	 0.05,
compared with untreated control, as determined by ANOVA
followed by Bonferroni’s multiple comparison test (n6–8).
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BM-DCs, the use of a BLT1 receptor antagonist (CP 105,696;
1 M) prior to LTB4 administration impaired Ca
2 mobiliza-
tion (data not shown).
FcR-mediated Syk activation is not
Ca2-dependent in BM-DCs
We have demonstrated previously that enhancement of Syk
activation by LTB4 in MØ is dependent on increases in intra-
cellular Ca2 [11]. Having established that LTB4 interaction
with its receptors indeed increases intracellular Ca2 concen-
tration in BM-DCs, we considered the possibility that FcR-
mediated Syk activation is not a Ca2-dependent process
in BM-DCs, which were pretreated with the extracellular




acid (BAPTA)-AM for 30 min before IgG-RBC challenge. As
observed in Figure 7A, FcR-mediated Syk activation in
BM-DCs was not inhibited by treatment with EGTA,
BAPTA-AM, or the combination. By contrast, pretreatment
with BAPTA-AM inhibited FcR-mediated Syk activation
in rat alveolar MØ (Fig. 7B), in BM-MØ (Fig. 7C), and in rat
peritoneal MØ (Fig. 7D). The ability of LTB4 treatment to
amplify FcR-mediated Syk activation in BM-MØ and in rat
peritoneal MØ is also illustrated in Figure 7, C and D,
respectively. As an alternative approach to comparing the
participation of Ca2 in Syk activation evoked by FcR
engagement in BM-DCs versus BM-MØ, we examined the
effect of the addition of the calcium ionophore A23187 on
FcR-mediated Syk activation. As observed in Figure 8A,
the treatment of BM-DCs with A23187 immediately before
the addition of IgG-coated RBCs did not change Syk phos-
phorylation. In contrast, the same procedure performed in
BM-MØ amplified FcR-mediated Syk activation (Fig. 8B).
Together, these results indicate that the process of Syk
activation in BM-DCs is Ca2-independent, in contrast to
that in MØ.
DISCUSSION
DCs avidly ingest IgG-coated targets, and activation of the
nonreceptor tyrosine kinase Syk is a pivotal, early step in this
process [2], as it is for MØ [1]. Syk activation has also been
implicated in maturation and antigen presentation of DCs [2].
In the present study, we have, for the first time, assessed the
role of LTs, important immunostimulatory lipid mediators, in
modulating FcR-induced phagocytosis as well as Syk activa-
tion in DCs. We examined the effects of exogenously supplied
LTs and also used genetic and pharmacologic approaches to
assess the role of endogenously generated LTs in these pro-
cesses. Our data demonstrate two substantial differences be-
tween murine BM-DCs and MØ. First, neither FcR-mediated
phagocytosis nor Syk activation in DCs was influenced by
exogenous or endogenous LTs. Second, FcR-mediated Syk
activation in DCs is not Ca2-regulated, as neither Ca2
chelators nor Ca2 ionophore treatment exerted any effect. As
our previous report indicated that the ability of LTB4 in par-
ticular to enhance FcR-induced phagocytosis and Syk acti-
vation in MØ was dependent on receptor-mediated increases in
intracellular Ca2 [11], it is likely that the Ca2 independence
of Syk activation in DCs accounts for the lack of modulation
by LTs.
We first verified that the two cell populations of interest
generated in vitro from BM-derived cells exhibited the flow
cytometric characteristics of BM-MØ and BM-DC phenotypes
(Fig. 1A). We used adherence to yield a population of imma-
Fig. 4. FcR-mediated Syk activation is not modu-
lated by LTB4 or by other 5-LO-derived products. (A)
LTB4 does not amplify FcR-mediated Syk activation.
BM-DCs were pretreated with LTB4 (100 nM) for 2 min
prior to the addition of IgG-RBCs (1:33 ratio). (B) A
LTB4 receptor antagonist (RA) does not change FcR-
mediated Syk activation. BM-DCs were pretreated with
the BLT1 receptor antagonist LY 292476 (10 M) for
10 min prior to the addition of IgG-RBCs (1:3 ratio). (C)
Inhibition of LT synthesis does not change FcR-me-
diated Syk activation. BM-DCs were pretreated with the
FLAP inhibitor MK 886 (1 M) or the 5-LO inhibitor zileuton (10 M) for 20 min prior to the addition of IgG-RBCs (1:100). Seven minutes after RBCs or IgG-RBC
challenge at 37°C, the incubations were terminated by addition of lysis buffer, and lysates were subjected to immunoprecipitation (ip) and immunoblotting (blot)
as described in Materials and Methods. Immunoblots in upper panels represent phosphorylated Syk detected with anti-PY antibody and those in lower panels, the
amounts of Syk protein evaluated with anti-Syk antibody. Results are representative of two separate experiments.
Fig. 5. Effect of 5-LO gene KO in FcR-mediated
Syk activation. BM-DCs obtained from WT (A) and
5-LO KO (B) mice were challenged with RBC (1:
40) or with increasing amounts of IgG-sRBC, as
indicated in the figure, and then incubated for 7
min at 37°C. Incubations were terminated by addi-
tion of lysis buffer, and lysates were subjected to
immunoprecipitation and immunoblotting as de-
scribed in Materials and Methods. Immunoblots in
upper panels represent phosphorylated Syk detected
with anti-PY antibody and those in lower panels, the amounts of Syk protein evaluated with anti-Syk antibody. Results are representative of two separate
experiments.
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ture DCs known to actively capture and process antigens and
migrate to the draining lymph nodes, wherein they increase
their ability to stimulate resting T cells, thereby initiating
various immune responses [21–23]. This fact was confirmed by
flow cytometric analysis, in which the adherent cell population
showed lower expression of MHC class II and higher expres-
sion of CD11c and FcR compared with the nonadherent cell
population. Also as expected, BM-MØ and BM-DCs exhibited
comparable capacity for mannose-dependent ingestion of dex-
tran, demonstrating the efficiency of the phagocytic machinery
for both cell types (Fig. 1B).
BM-DCs have been reported to produce LTB4 and cysLTs
upon stimulation with lipopolysaccharide or antigen [24, 25]
and to express the biosynthetic proteins necessary to initiate
LT synthesis from AA, namely 5-LO and FLAP [25]. Further-
more, DCs have been shown to express receptors for cysLTs
[25, 26], which have been implicated in DC migration to [26]
and from [6] tissue sites of antigen challenge. Although LTB4
has been reported to stimulate production of IL-6 as well as
BM-DC generation when added to BM cultures [21], the re-
ceptors for LTB4 have not been examined previously in DCs.
Certainly, the inability of endogenous or exogenous LTB4 to
modulate FcR-induced phagocytosis and Syk activation in
BM-DCs could be the consequence of lack of expression of the
high-affinity receptor BLT1. However, RT-PCR and immuno-
blot analyses revealed expression of BLT1 in BM-DCs. It has
previously been reported that in contrast to epidermal MØ or
peripheral blood monocytes, epidermal DCs from humans fail
to mobilize intracellular Ca2 in response to a variety of
proinflammatory stimuli, including interleukin-1, bradykinin,
Fig. 6. LTB4 evokes Ca
2 mobilization in BM-DCs, which were incubated
with 10 M Fura-2-AM for 30 min, washed, and resuspended at a density of
107 cells/ml into the magnetically stirred cuvette of the luminescence spec-
trometer. Calcium mobilization was monitored for 80 s (stabilization), and
then the cells were treated with LTB4 (100 nM). Calcium mobilization is
expressed as a fluorescence ratio obtained from 340 and 380 (340/380) nm.
Results are representative of two separate experiments.
Fig. 7. Effect of Ca2 chelators on FcR-medi-
ated Syk activation. (A) Ca2 chelators do not mod-
ify FcR-mediated Syk activation in BM-DCs,
which were pretreated with EGTA (1 mM),
BAPTA-AM (10 M), or with both in the same
doses for 30 min prior to the addition of IgG-RBCs
(1:3 ratio). (B) Inhibition of FcR-mediated Syk
activation by BAPTA-AM in rat alveolar MØ, which
were pretreated with EGTA (10 mM) or
BAPTA-AM (50 M) for 30 min prior to the addi-
tion of IgG-RBCs (1:100 ratio). (C) Inhibition of
FcR-mediated Syk activation by BAPTA-AM in
BM-MØ, which were pretreated with BAPTA-AM
(50 M) for 30 min or with LTB4 (100 nM) 2 min
prior to the addition of IgG-RBCs (1:30 ratio). (D)
Inhibition of FcR-mediated Syk activation by
BAPTA-AM in rat peritoneal MØ, which were pre-
treated with BAPTA-AM (50 M) for 30 min or
with LTB4 (100 nM) 2 min prior to the addition of
IgG-RBCs (1:30 ratio). Seven minutes after RBCs
or IgG-RBC challenge at 37°C, the incubations
were terminated by addition of lysis buffer, and
lysates were subjected to immunoprecipitation and
immunoblotting as described in Materials and Methods. Immunoblots in upper panels represent phosphorylated Syk detected with anti-PY antibody and those in
lower panels, the amounts of Syk protein evaluated with anti-Syk antibody. Results are representative of two separate experiments.
Fig. 8. Effect of Ca2 ionophore on FcR-mediated Syk activation. (A) Ca2
ionophore does not modify FcR-mediated Syk activation in BM-DCs, which
were treated with A23187 (1 M) immediately before the addition of IgG-
RBCs (1:3 ratio). (B) Ca2 ionophore amplifies FcR-mediated Syk activation
in BM-MØs, which were treated with A23187 (1 M) immediately before the
addition of IgG-RBCs (1:25 ratio). Seven minutes after RBCs or IgG-RBC
challenge at 37°C, the incubations were terminated by addition of lysis buffer,
and lysates were subjected to immunoprecipitation and immunoblotting as
described in Materials and Methods. Immunoblots in upper panels represent
phosphorylated Syk detected with anti-PY antibody and those in lower panels,
the amounts of Syk protein evaluated with anti-Syk antibody. Results are
representative of two separate experiments.
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and formyl-Met-Leu-Phe [27]. This raised the possibility that
LTB4 ligation of BLT1 might be incapable of triggering an
intracellular Ca2 flux in the BM-DCs under investigation
here. It is important, however, that the functional competence
of this receptor was established by demonstrating intact LTB4-
induced Ca2 mobilization, which was inhibitable by a BLT1-
selective antagonist. Thus, the refractoriness of BM-DCs to
LTB4 cannot be explained by the absence of its high-affinity
receptor BLT1 or its inability to signal appropriately via Ca2
mobilization.
Like BLT1, the high-affinity receptor for cysLTs (cysLT1) is
also a Gq-coupled receptor. That ligation of these two dis-
crete Ca2-coupled LT receptors in BM-DCs failed to modu-
late FcR-mediated phagocytosis and Syk activation suggested
the alternative possibility that such processes were indepen-
dent of Ca2 in these cell types. Experiments using Ca2
chelators and ionophores demonstrated that this was indeed the
case for Syk activation in BM-DCs. This contrasts with parallel
findings in murine BM-MØ as well as rat alveolar and perito-
neal MØ, in which Syk activation was clearly modulated by
changes in intracellular Ca2. As other DC functions are
well-recognized to be regulated by Ca2 [28], the Ca2 inde-
pendence of Syk regulation reflects a selective property of
murine BM-DCs.
Little is known about how increased intracellular Ca2
enhances Syk activation in MØ. Nevertheless, this mode of
regulation might be expected to provide a means by which
many proinflammatory ligands for Gq-coupled receptors
could amplify FcR-mediated phagocytosis essential for anti-
microbial defense. The fact that this mechanism is not opera-
tive in DCs, at least in the immature murine BM-DCs under
investigation here, reveals cell-specific differences in the
means by which these two types of monocyte-derived phago-
cytic cells are regulated. Although the teleologic explanation
for distinct regulatory mechanisms in DCs is at this point
unknown, one can speculate that it may reflect differences in
the milieu in which these cells encounter IgG-coated targets or
in the functional significance of the phagocytic process. Cer-
tainly, the functional consequences of FcR-mediated inges-
tion are widely divergent between MØ (microbial killing) and
DCs (antigen processing for its eventual presentation), and
these downstream responses may conceivably be differentially
regulated by Ca2. Consistent with this possibility is the fact
that in contrast to monocytes or MØ, DCs fail to mobilize Ca2
[27] or generate reactive oxygen intermediates [19] in response
to FcR ligation. It remains to be determined whether the
differences we have identified in the regulation of Syk activa-
tion contribute to divergent, functional consequences of FcR
ligation in the two cell types.
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